Auszug
Kein Kapitel auf dem Gebiet der gastroenterologischen Erkrankungen erfuhr in den vergangenen Jahrzehnten das Privileg, so grundlegend neu geschrieben werden zu dürfen, wie das zur Gastritis und zur peptischen Ulkuskrankheit. Die Entdeckung von Helicobacter pylori, der medizinischen Fachwelt erstmals 1983 zugänglich gemacht, hat innerhalb nur weniger Jahre zu wesentlichen neuen Erkenntnissen geführt, sodass bereits 1990 ein neues System der Gastritisklassifikation (Sydney-System) zur verbindlichen Empfehlung für den klinischen Pathologen und Gastroenterologen vorgestellt wurde. Diese Einteilung stellt die Grundlage für eine ursachenorientierte spezifische Klassifikation und Therapie der Gastritis dar. Allerdings müssen für die Therapieentscheidung bei Gastritis auch die begleitenden klinischen Manifestationen neu miteinbezogen werden.
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Dixon MF, Genta RM, Yardley JH, Correa P (1996) The updated Sydney system. Am J Surg Pathol 20:1161–1181
Irvine EJ, Hunt RH (2001) Evidencebased Gastroenterology. BC Decker, Inc. Hamilton, London
Malfertheiner P (2000) Helicobacter pylori — Von der Grundlage zur Therapie, 3. Aufl. Thieme, Stuttgart
Malfertheiner P, Leodolter A, Peitz U (2000) Cure of H. pyloriasso-ciated ulcer disease through eradication. In: Tytgat GNJ (ed) Bailliere’s Best Practice; Research Clinical Gastroenterology. Harcourt Publisher Ltd., 14(1): 119–132
Malfertheiner P, Megraud F, O’Morain C, Hingin APS, Jones R, Axon A, Graham DY, Tytgat G (2002) Current concepts in the management of Helicobacter pylori infection — The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16: 167–180
Malfertheiner P, Megraud F, O’Morain C, Hingin APS, Jones R, Axon A, Graham DY, Tytgat G (im Druck) Current concepts in the management of Helicobacter pylori infection — The Maastricht 3-Consensus Report. Aliment Pharmacol Ther 16: 167–180
Malfertheiner P, Peitz U, Wolle K, Treiber G, (2004) H. pyloriintectionan update for 2004. Dtsch Med Wochenschr 129:1821–1826
Perri F, Festa V, Clemente R, Quitadamo M, Audriulli A (2000) Ritabutinbased ‘rescue therapie’ for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther 14:311–316
Price AB (1991) The Sydney system: histological division. J Gastroenterol Hepatol 6:209–222
Stolte M, Meining A (2001) The updated Sydney system: classification and grading of gastritis at the basis of diagnosis and treatment. Can J Gastroenterol 15(9): 591–598
Sung JJY, Russel RI, Yeomans N, Chan FKL et al. (2000) Working party report: Nonsteroidal antiinflammatory drug toxicity in the upper gastrointestinal tract. J Gastroenterol Hepatol 15: 58–68
Literatur
Anlauf M, Garbrecht N, Henopp et al. (2006) Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological end and epidemiological features. World J Gastronterol 12(34): 5440–6
Arnold R, Trautmann ME, Creutzfeldt W et al. (1996) Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38:430–438
Chandrasekharappa SC, Guru SC, Manickam P et al. (1997) Positional cloning of the gene for multiple endocrine neoplasiatype 1. Science 276: 404–407
De Jong M, Valkema R, Jamar F et al. (2002) Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. Semin Nucl Med. 32(2): 133–40
Eriksson BK, Larsson EG, Skogseid BM et al. (1998) Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 83: 2293–2301
Gibril F, Schumann M, Pace A (2004) Multiple endocrine neoplasia Type 1 and Zollinger-Ellison-Syndrome. Medicine 83: 43–83
Malfertheiner P, Peitz U, Wolle K (2004) Htipylori infection-an update for 2004. Dtsch Med Wochenschr129:1821–1826
Marx S, Spiegel AM, Skarulis MC et al. (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129:484–494
Norton JA, Fraker DL, Alexander HR et al. (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341: 635–644
Norton JA, Alexander HR, Fraker DL et al. (2001) Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type I and Zollinger-Ellison syndrome. Ann Surg 234: 495–505
Norton JA, Fang TD, Jensen RT. (2006) Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1. J Nat Compr Canc Netw 4(2) 148–153
Öberg K (1994) Biology, diagnosis, and treatment of neuroendocrine tumors of the gastrointestinal tract. Curr Opin Oncol 6:441–451
Perri F, Festa V, Clemente R (2000) Rifabutinbased ‘rescue therapy’ for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther 14311–316
Schrenck T von, Howard JM, Doppman JL et al. (1988) Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 94: 1326–1334
Termanini B, Gibril F, Reynolds JC et al. (1997) Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma and of its effect on clinical management. Gastroenterology 112: 335–347
Thompson NW, Pasieka J, Fukuuchi A et al. (1993) Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome. World J Surg 17: 455–462
Literatur
Macdonald JS, Smalley S et al. (2001) Chemoradiotherapy after surgery alone for adenocarcinoma of the stomach or gastrooesophageal junction. N Engl J Med 345: 725–730
Partyka S, Dumas P, Ajani J (1999) Combination chemotherapy with granulocytemacrophagecolony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma. Cancer 85: 2336–2339
Petrasch S (1998) Neoadjuvante, adjuvante und palliative Chemotherapie des Magenkarzinoms. Verdauungskrankheiten 16(4): 167–174
Schilling D, Martin WR, Benz C, Kress S, Riemann JF (1997) Langzeitergebnisse der endoskopischen Ballondilatation ulkusbedingter Magenausgangsstenosen — Followup von 25 Patienten. Z Gastroenterol 35: 105–108
Waters JS, Norman A, Cunningham D et al. (1999) Longterm survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer 80: 269–272
Literatur
Cogliatti SB, Schmid U, Schumacher U et al. (1991) Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 101: 1159–1170
Eck M, Schmaußer W, Haas R et al. (1997) MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the Cag A protein. Gastroenterology 112: 1482–1486
Fischbach W (2000) Gastrointestinale Lymphome. Ätiologie, Pathogenese und Therapie. Internist 41:831–840
Fischbach W, Dragosics B, Kolve ME et al. (2000) Management of primary gastric B-cell lymphoma: Results of a prospective multicenter study. Gastroenterology 25: 509–512
Fischbach W, Goebeler M, Staristik P et al. (2002) Minimal residual lowgrade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 360: 547–548
Fischbach W, Goebeler M, Greiner A (2002) Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage. Gastrointest Endosc 56: 696–700
Fischbach W, Goebeler M. Dragosics B, Greiner A, Stolte M (2004) Longterm outcome of patients with gastric marginal zone B-cell lymphoma of MALT following exclusive Helicobacter pylori eradication therapy. Experience from a large prospective series. GUT 53: 34–37
Koch P, Del Valle F, Berdel W et al. (2001) Primary gastrointestinal Non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma. Results of the prospective German multicenter study GIT NHL 01/92. J Clin Oncol 19: 3874–3883
Morgner A, Miehlke S, Fischbach W et al. (2001) Complete remission of primary highgrade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 19:2041–2048
Radaszkiewicz T, Dragosics B, Bauer P (1992) Gastrointestinal malignant lymphomas of the mucosaassociated lymphoid tissue. Factors relevant to prognosis. Gastroenterology 102: 1628–1638
Schechter NR, Portlock CS, Yahalom J (1998) Treatment of mucosaassociated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 16: 1916–1921
Sonnen R, Calavrezos A, Grimm HA, Kuse R (1994) Kombinierte konservative Behandlung von lokalisierten Magenlymphomen. Dtsch Med Wochenschr119:863–868
Stolte M (1992) Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet 339: 745
Strecker P, Eck M, Greiner A et al. (1998) Diagnostische Aussagekraft der Magenbiopsie im Vergleich zum Resektat bei primären gastralen B-Zell-Lymphomen vom MALT-Typ. Pathologe 19: 209–213
Wotherspoon AC, Doglioni C, Diss TC et al. (1993) Regression of primary lowgrade B-cell gastric lymphoma of mucosaassociated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342: 575–577
Literatur
Baron TH, Harewood GC (2003) Enteral selfexpandable stents. Gastrointest Endosc 58: 421–433
Bleau BL, Gostout CJ, Sherman KE et al. (2002) Recurrent bleeding from peptic ulcer associated with adherend clot: a randomised study comparing endoscopic treatment with medical therapy. Gastrintest Endosc 56: 2–6
Bohnacker S, Seitz U, Nguyen D et al. (2005) Endoscopic resection of benign tumors of the duodenal papilla without and with intraductal growth. Gastrointest Endosc 62(4): 551–560
Classen M, Tytgat GNJ, Lightdale JC (Hrsg) (2004) Gastroenterologische Endoskopie. Thieme, Stuttgart New York
Eisen GM, Baron TH, Dominitz JA et al. (2002) Guideline for the management of ingested foreign bodies. Gastrointest Endosc 55: 802–806.
Gotoda T, Yanagisawa A, Sasako M et al (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centres. Gastric Cancer; 3: 219–225
Ida K, Nakazawa S, Yoshino J et al. (2004) Multicentre collaborative prospective study of endoscopic treatment of early gastric cancer. Dig Endosc 16: 295–302
Greten H, Jäckle S, Thonke F Soehendra N (2001) Endoskopische Therapie bei nichtvariköser und variköser gastrointestinaler Blutung. DÄ 98: A 604–111
Hahn EG, Riemann JF (Hrsg) (1996) Klinische Gastroenterologie. Thieme, Stuttgart New York
Lo GH, Lai KH, Cheng JS et al. (2001) A prospektive randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 33:1060–1064
Oda I, Gotoda T, Hamanaka H et al. (2005) Endoscopic submucosal dissection for early gastric cancer: technical feasability, operation time and complications from a large consecutive series. Dig Endoscopy2005; 17: 54–58
Solt J, Bajor J, Szabó, Horváth ÖP (2003) Longterm results of balloon catheter dilation for benign gastric outlet stenosis. Endoscopy 35: 490–495
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Malfertheiner, P. et al. (2007). Gastroduodenale Erkrankungen. In: Schölmerich, J. (eds) Medizinische Therapie 2007 | 2008. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48554-4_68
Download citation
DOI: https://doi.org/10.1007/978-3-540-48554-4_68
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-48553-7
Online ISBN: 978-3-540-48554-4
eBook Packages: Medicine (German Language)